Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 172

1.

Chicken adaptive response to low energy diet: main role of the hypothalamic lipid metabolism revealed by a phenotypic and multi-tissue transcriptomic approach.

Jehl F, Désert C, Klopp C, Brenet M, Rau A, Leroux S, Boutin M, Lagoutte L, Muret K, Blum Y, Esquerré D, Gourichon D, Burlot T, Collin A, Pitel F, Benani A, Zerjal T, Lagarrigue S.

BMC Genomics. 2019 Dec 30;20(1):1033. doi: 10.1186/s12864-019-6384-8.

2.

Bone penetration of daptomycin in diabetic patients with bacterial foot infections.

Grillon A, Argemi X, Gaudias J, Ronde-Ousteau C, Boeri C, Jenny JY, Hansmann Y, Lefebvre N, Jehl F.

Int J Infect Dis. 2019 Aug;85:127-131. doi: 10.1016/j.ijid.2019.05.011. Epub 2019 May 13.

3.

Breakpoint to MIC quotient: A parameter to rapidly evaluate the in vitro bactericidal activity of β-lactams on Enterobacteriaceae.

Grillon A, Chabaud A, Zambardi G, Caniaux I, Jehl F.

Int J Antimicrob Agents. 2019 May;53(5):674-677. doi: 10.1016/j.ijantimicag.2019.01.013. Epub 2019 Feb 1.

PMID:
30716447
4.

Tobramycin and Amikacin Delay Adhesion and Microcolony Formation in Pseudomonas aeruginosa Cystic Fibrosis Isolates.

Olivares E, Badel-Berchoux S, Provot C, Jaulhac B, Prévost G, Bernardi T, Jehl F.

Front Microbiol. 2017 Jul 11;8:1289. doi: 10.3389/fmicb.2017.01289. eCollection 2017.

5.

Kinetics of biofilm formation by Staphylococcus lugdunensis strains in bone and joint infections.

Argemi X, Prévost G, Riegel P, Provot C, Badel-Berchoux S, Jehl F, Olivares E, Hansmann Y.

Diagn Microbiol Infect Dis. 2017 Aug;88(4):298-304. doi: 10.1016/j.diagmicrobio.2017.05.002. Epub 2017 May 12.

PMID:
28529089
6.

Long noncoding RNA repertoire in chicken liver and adipose tissue.

Muret K, Klopp C, Wucher V, Esquerré D, Legeai F, Lecerf F, Désert C, Boutin M, Jehl F, Acloque H, Giuffra E, Djebali S, Foissac S, Derrien T, Lagarrigue S.

Genet Sel Evol. 2017 Jan 10;49(1):6. doi: 10.1186/s12711-016-0275-0.

8.

The BioFilm Ring Test: a Rapid Method for Routine Analysis of Pseudomonas aeruginosa Biofilm Formation Kinetics.

Olivares E, Badel-Berchoux S, Provot C, Jaulhac B, Prévost G, Bernardi T, Jehl F.

J Clin Microbiol. 2016 Mar;54(3):657-61. doi: 10.1128/JCM.02938-15. Epub 2015 Dec 30.

9.

Towards a definition of daptomycin optimal dose: Lessons learned from experimental and clinical data.

Senneville E, Caillon J, Calvet B, Jehl F.

Int J Antimicrob Agents. 2016 Jan;47(1):12-9. doi: 10.1016/j.ijantimicag.2015.11.005. Epub 2015 Nov 29. Review.

PMID:
26712134
10.

Susceptibility trends including emergence of linezolid resistance among coagulase-negative staphylococci and meticillin-resistant Staphylococcus aureus from invasive infections.

Decousser JW, Desroches M, Bourgeois-Nicolaos N, Potier J, Jehl F, Lina G, Cattoir V, Vandenesh F, Doucet-Populaire F; Microbs Study Group.

Int J Antimicrob Agents. 2015 Dec;46(6):622-30. doi: 10.1016/j.ijantimicag.2015.07.022. Epub 2015 Sep 25.

PMID:
26453147
11.

In vivo macrophage imaging using MR targeted contrast agent for longitudinal evaluation of septic arthritis.

Bierry G, Lefevre S, Dietemann JL, Jehl F.

J Vis Exp. 2013 Oct 20;(80):e50296. doi: 10.3791/50296.

12.

Multicomponent antibiotic substances produced by fermentation: implications for regulatory authorities, critically ill patients and generics.

Brink AJ, Richards GA, Colombo G, Bortolotti F, Colombo P, Jehl F.

Int J Antimicrob Agents. 2014 Jan;43(1):1-6. doi: 10.1016/j.ijantimicag.2013.06.013. Epub 2013 Aug 3. Review.

PMID:
23920094
13.

Cateslytin, a chromogranin A derived peptide is active against Staphylococcus aureus and resistant to degradation by its proteases.

Aslam R, Marban C, Corazzol C, Jehl F, Delalande F, Van Dorsselaer A, Prévost G, Haïkel Y, Taddei C, Schneider F, Metz-Boutigue MH.

PLoS One. 2013 Jul 24;8(7):e68993. doi: 10.1371/journal.pone.0068993. Print 2013.

14.

In vitro activity of daptomycin against Enterococcus faecalis under various conditions of growth-phases, inoculum and pH.

Argemi X, Hansmann Y, Christmann D, Lefebvre S, Jaulhac B, Jehl F.

PLoS One. 2013 May 21;8(5):e64218. doi: 10.1371/journal.pone.0064218. Print 2013.

15.

Efficacy of intravitreal administrations of linezolid in an experimental model of S. aureus-related endophthalmitis.

Saleh M, Lefèvre S, Acar N, Bourcier T, Marcellin L, Prévost G, Subilia A, Gaucher D, Jehl F.

Invest Ophthalmol Vis Sci. 2012 Jul 20;53(8):4832-41. doi: 10.1167/iovs.11-8417.

PMID:
22661478
16.

Daptomycin versus vancomycin in a methicillin-resistant Staphylococcus aureus endophthalmitis rabbit model: bactericidal effect, safety, and ocular pharmacokinetics.

Lefèvre S, Saleh M, Marcellin L, Subilia A, Bourcier T, Prévost G, Jehl F.

Antimicrob Agents Chemother. 2012 May;56(5):2485-92. doi: 10.1128/AAC.05745-11. Epub 2012 Feb 27.

17.

Ocular penetration of linezolid after oral administration in rabbits.

Saleh M, Lefevre S, Bourcier T, Prevost G, Gaucher D, Speeg-Schatz C, Jehl F.

J Ocul Pharmacol Ther. 2011 Jun;27(3):243-6. doi: 10.1089/jop.2010.0157. Epub 2011 Apr 21.

PMID:
21510740
18.

Septic arthritis: monitoring with USPIO-enhanced macrophage MR imaging.

Lefevre S, Ruimy D, Jehl F, Neuville A, Robert P, Sordet C, Ehlinger M, Dietemann JL, Bierry G.

Radiology. 2011 Mar;258(3):722-8. doi: 10.1148/radiol.10101272.

PMID:
21339348
19.

Enhanced physician adherence to antibiotic use guidelines through increased availability of guidelines at the time of drug ordering in hospital setting.

Westphal JF, Jehl F, Javelot H, Nonnenmacher C.

Pharmacoepidemiol Drug Saf. 2011 Feb;20(2):162-8. doi: 10.1002/pds.2078. Epub 2010 Dec 23.

PMID:
21254287
20.

MRI of macrophages in infectious knee synovitis.

Bierry G, Jehl F, Neuville A, Lefevre S, Robert P, Kremer S, Dietemann JL.

AJR Am J Roentgenol. 2010 Jun;194(6):W521-6. doi: 10.2214/AJR.09.3768.

PMID:
20489072
21.

[Comparative study of Vitek-2™ AIX versus Vitek-2™ PC: phenotypic resistance of enterobacteriaceae to β-lactams].

Lefèvre S, Cocquerelle V, Riegel P, Scheftel JM, Jaulhac B, Jehl F.

Pathol Biol (Paris). 2012 Apr;60(2):78-83. doi: 10.1016/j.patbio.2010.01.002. Epub 2010 Apr 7. French.

PMID:
20378278
22.

Ocular penetration of topically applied linezolid in a rabbit model.

Saleh M, Jehl F, Dory A, Lefevre S, Prevost G, Gaucher D, Sauer A, Speeg-Schatz C, Bourcier T.

J Cataract Refract Surg. 2010 Mar;36(3):488-92. doi: 10.1016/j.jcrs.2009.09.036.

PMID:
20202550
23.

[Extension of antimicrobial drugs resistance: two clinical isolates of Klebsiella pneumoniae with cephalosporinase].

Gueudet T, Richter S, Szulc M, Jehl F.

Med Mal Infect. 2010 Mar;40(3):177-9. doi: 10.1016/j.medmal.2009.08.004. Epub 2009 Oct 1. French. No abstract available.

PMID:
19800186
24.

Cellular magnetic resonance imaging for the differentiation of infectious and degenerative vertebral disorders: preliminary results.

Bierry G, Jehl F, Holl N, Sibilia J, Froelich S, Froehlig P, Dietemann JL, Kremer S.

J Magn Reson Imaging. 2009 Oct;30(4):901-6. doi: 10.1002/jmri.21904.

PMID:
19787738
25.

Molecular determinants of fluoroquinolone antibacterial agents pharmacokinetics.

Levêque D, Jehl F.

Curr Clin Pharmacol. 2009 Sep;4(3):191-7. Epub 2009 Sep 1. Review.

PMID:
19500069
26.

Macrophage imaging by USPIO-enhanced MR for the differentiation of infectious osteomyelitis and aseptic vertebral inflammation.

Bierry G, Jehl F, Boehm N, Robert P, Dietemann JL, Kremer S.

Eur Radiol. 2009 Jul;19(7):1604-11. doi: 10.1007/s00330-009-1319-4. Epub 2009 Feb 6.

PMID:
19198846
27.

[Advantages of corticosteroids in managing acute bacterial postoperative endophthalmitis].

Saleh M, Jehl F, Prevost G, Speeg-Schatz C, Bourcier T.

J Fr Ophtalmol. 2008 Oct;31(8):825-33. Review. French.

PMID:
19107051
28.

Percutaneous inoculated rabbit model of intervertebral disc space infection: magnetic resonance imaging features with pathological correlation.

Bierry G, Jehl F, Prévost G, Mohr M, Meyer N, Dietemann JL, Kremer S.

Joint Bone Spine. 2008 Jul;75(4):465-70. doi: 10.1016/j.jbspin.2007.06.018. Epub 2008 May 15.

PMID:
18485785
29.

Macrophage activity in infected areas of an experimental vertebral osteomyelitis model: USPIO-enhanced MR imaging--feasibility study.

Bierry G, Jehl F, Boehm N, Robert P, Prévost G, Dietemann JL, Desal H, Kremer S.

Radiology. 2008 Jul;248(1):114-23. doi: 10.1148/radiol.2481071260. Epub 2008 May 5.

PMID:
18458246
30.

[Evolution of antibiotic resistance of Streptococcus pneumoniae: results of Alsace observatory in 2005].

Gravet A, Camdessoucens G, Murbach V, Barrand P, Boucher A, Boulenc A, De Briel D, Delarbre JM, Drzewinski JC, Flipo JL, Gherardi C, Grawey I, Gueudet T, Heidt A, Herzig V, Izraelewicz D, Jehl F, Kientz P, Lantz V, Lemble C, Pierrot P, Rieder C, Riehm D, Tytgat F.

Pathol Biol (Paris). 2007 Nov;55(8-9):424-8. Epub 2007 Sep 25. French.

PMID:
17897789
31.

Molecular pharmacokinetics of catharanthus (vinca) alkaloids.

Levêque D, Jehl F.

J Clin Pharmacol. 2007 May;47(5):579-88. Review.

PMID:
17442684
32.

[Use of linezolid for the treatment of lung infections in adults with cystic fibrosis].

Betton D, Gairard-Dory AC, Kessler R, Jehl F, Rosner V, Weitzenblum E, Beretz L.

Rev Pneumol Clin. 2006 Dec;62(6 Pt 1):374-8. French.

PMID:
17242642
33.

[Microbial description of bacteriuria in long-term care facilities: a prospective study in the French Teaching Hospital of Strasbourg].

Lang PO, Jehl F, Berthel M, Kaltenbach G.

Med Mal Infect. 2006 May;36(5):280-4. Epub 2006 Apr 27. French.

PMID:
16644164
34.

Clinical pharmacokinetics of voriconazole.

Levêque D, Nivoix Y, Jehl F, Herbrecht R.

Int J Antimicrob Agents. 2006 Apr;27(4):274-84. Epub 2006 Mar 24. Review.

PMID:
16563707
35.

Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation.

Mariat C, Venet C, Jehl F, Mwewa S, Lazarevic V, Diconne E, Fonsale N, Carricajo A, Guyomarc'h S, Vermesch R, Aubert G, Bidault R, Bertrand JC, Zeni F.

Crit Care. 2006 Feb;10(1):R26.

36.

Pharmacokinetics of therapeutic monoclonal antibodies used in oncology.

Levêque D, Wisniewski S, Jehl F.

Anticancer Res. 2005 May-Jun;25(3c):2327-43.

37.

[Pharmacodynamics: a determining factor in choosing a glycopeptide].

Jehl F.

Med Mal Infect. 2004 Jun;34 Suppl 1:S92-6. French. No abstract available.

PMID:
15676258
38.

Randomized comparison of serum teicoplanin concentrations following daily or alternate daily dosing in healthy adults.

Rouveix B, Jehl F, Drugeon H, Brumpt I, Caulin E.

Antimicrob Agents Chemother. 2004 Jul;48(7):2394-9.

39.

Determination of fosmidomycin in human serum and urine by capillary electrophoresis.

Bronner S, Renault C, Hintz M, Wiesner J, Jomaa H, Monteil H, Jehl F.

J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Jul 5;806(2):255-61.

PMID:
15171936
40.

The effect of rifampin on the pharmacokinetics of vinorelbine in the micropig.

Leveque D, Wisniewski S, Renault C, Peter JD, Le Corre P, Monteil H, Jehl F.

Anticancer Res. 2003 May-Jun;23(3B):2741-4.

PMID:
12894568
41.

Moxifloxacin efficacy and vitreous penetration in a rabbit model of Staphylococcus aureus endophthalmitis and effect on gene expression of leucotoxins and virulence regulator factors.

Bronner S, Jehl F, Peter JD, Ploy MC, Renault C, Arvis P, Monteil H, Prevost G.

Antimicrob Agents Chemother. 2003 May;47(5):1621-9.

42.

Ex vivo pharmacodynamics of amoxicillin-clavulanate against beta-lactamase-producing Escherichia coli in a yucatan miniature pig model that mimics human pharmacokinetics.

Bronner S, Murbach V, Peter JD, Levêque D, Elkhaïli H, Salmon Y, Dhoyen N, Monteil H, Woodnutt G, Jehl F.

Antimicrob Agents Chemother. 2002 Dec;46(12):3782-9.

43.

[Sinusal penetration of amoxicillin-clavulanic acid. Formulation 1 g./125 mg., twice daily versus formulation 500 mg./125 mg., three times daily].

Jehl F, Klossek JM, Peynegre R, Serrano E, Castillo L, Bobin S, Desprez D, Renault C, Neel V, Rouffiac E, Borie C.

Presse Med. 2002 Oct 19;31(34):1596-603. French.

PMID:
12426976
44.

[Urinary tract infections due to wide spectrum beta lactamase producing enterobacteriaceae].

Kaltenbach G, Heitz D, Vogel T, Noblet-Dick M, Martin-Hunyadi C, Kiesmann M, Jehl F, Berthel M, Kuntzmann F.

Presse Med. 2002 Aug 10;31(26):1211-5. French.

PMID:
12212511
45.

High-level cephalosporinase-producing Enterobacter cloacae meningitis in a newborn.

Cavalier A, Murbach V, Astruc D, Monteil H, Simeoni U, Prevost G, Messer J, Jehl F.

Clin Microbiol Infect. 1999 Jul;5(7):444-446. No abstract available.

46.

Evidence for a true post-beta-lactamase-inhibitor effect of clavulanic acid against Klebsiella pneumoniae and Haemophilus influenzae.

Murbach V, Dhoyen N, Linger L, Monteil H, Jehl F.

Clin Microbiol Infect. 2001 Dec;7(12):661-5.

47.

[Chronic experimental bacteremia in Yucatan micropigs].

Peter JD, Murbach V, Bronner S, Levêque D, Kaltenbach G, Salmon Y, Dhoyen N, Desprez D, Hamel G, Monteil H, Jehl F.

Pathol Biol (Paris). 2001 Sep;49(7):576-82. French.

PMID:
11642022
48.

Ex vivo 12 h bactericidal activity of oral co-amoxiclav (1.125 g) against beta-lactamase-producing Haemophilus influenzae.

Bronner S, Pompei D, Elkhaïli H, Dhoyen N, Monteil H, Jehl F.

J Antimicrob Chemother. 2001 Oct;48(4):501-6.

PMID:
11581228
49.

[Predictive pharmacodynamic criteria and efficacy of augmentin 1 g/125 mg in 2 doses per day].

Jehl F.

Presse Med. 2000 Sep;29(26 Suppl):9-10. French. No abstract available.

PMID:
11045112
50.

[Bacterial growth delay in E. coli: demonstration and evaluation of the beta-lactamase post-inhibitor effect on 6 strains with different resistance phenotypes].

Murbach V, Bronner S, Dhoyen N, Sougakoff W, Monteil H, Jehl F.

Pathol Biol (Paris). 2000 Jun;48(5):478-84. French.

PMID:
10949845

Supplemental Content

Support Center